4-(1-Methyl-2-(2-methylprop-1-enyl)imidazol-5-yl)-2-anilinopyrimidine → HCID 69314355, Verbindung

HRID 2117759Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2117759
[CH3:1][N:2]1[C:6]([C:7]2[CH:12]=[CH:11][N:10]=[C:9]([NH:13][C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=3)[N:8]=2)=[CH:5][N:4]=[C:3]1[CH:20]=[C:21]([CH3:23])[CH3:22]>C(O)C.[Pd]>[CH3:1][N:2]1[C:6]([C:7]2[CH:12]=[CH:11][N:10]=[C:9]([NH:13][C:14]3[CH:15]=[CH:16][CH:17]=[CH:18][CH:19]=3)[N:8]=2)=[CH:5][N:4]=[C:3]1[CH2:20][CH:21]([CH3:23])[CH3:22]

Komponenten

4

Edukt 1

HCID 693092264-(1-Methyl-2-(2-methylprop-1-enyl)imidazol-5-yl)-2-anilinopyrimidine

Produkt 1

HCID 69314355HCID 69314355, VerbindungAusbeute 71 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 23938PalladiumKatalysatorHCID 702EthanolLösungsmittel

Versuchsvorschrift

4-(1-Methyl-2-(2-methylprop-1-enyl)imidazol-5-yl)-2-anilinopyrimidine (method 110; 400 mg, 1.3 mmol), and 10% Pd on C catalyst (150 mg), in ethanol (50 ml), was hydrogenated at 40 C and 20 bar for 18 hours. The catalyst was removed by filtration and the filter pad washed with ethanol. The solvent was evaporated and the residue triturated with ether and collected by filtration to give the title compound (280 mg, 71%). M/z: 308.

Aufarbeitung

  1. customThe catalyst was removed by filtration
  2. washthe filter pad washed with ethanol
  3. customThe solvent was evaporated
  4. customthe residue triturated with ether
  5. filtrationcollected by filtration

Quellen und Nachweise

ORD-Eintrag
ord-29c1ce49c6e043ca9c89de0e1ce2ea06
Quelldatensatz
uspto-grants-2008_10
Patentnummer
US07442697B2

Notizen zur Reaktion

Wird geladen…